Browsing by Subject "cancer-associated thrombosis"
Now showing items 1-2 of 2
-
Direct Oral Anticoagulant Use in Atypical Thrombosis-Related Conditions
( SAGE Publications Inc. , 2018 , Article Review)Objective: To review the published literature for evidence of the efficacy and safety of direct oral anticoagulants (DOACs) when used in the management of atypical thrombosis-related conditions. Data Sources: A comprehensive ... -
The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
( SAGE , 2021 , Article)Cancer-associated thrombosis (CAT) carries significant morbidity and mortality. Low-molecular-weight heparin (LMWH) remains the standard of care, with recent systematic studies suggesting the efficacy and safety of rivaroxaban ...